Houston

Texas' rebooted cancer agency shifting priorities

Underfunded tumors, commercialization of therapies new focus

November 30, 2014 Updated: November 30, 2014 7:50pm

After a series of scandals threatened its existence, Texas' $3 billion cancer-fighting agency is switching gears to emphasize underfunded, hard-to-treat tumors and the commercialization of new therapies.

Todd Ackerman

Todd Ackerman

Medical Reporter, Houston Chronicle